Emmanuel Nsutebu
Overview
Explore the profile of Emmanuel Nsutebu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
1047
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nsutebu E, AlDhaheri F, Albasata H, Aldhanhani H, Hussein S, Hammadi A
Postgrad Med J
. 2024 Feb;
100(1185):443-444.
PMID: 38376178
No abstract available.
2.
Aydin S, Mert A, Yilmaz M, Al Maslamani M, Rahimi B, Ayoade F, et al.
Mycoses
. 2024 Jan;
67(1):e13687.
PMID: 38214425
Background: During the COVID pandemic, research has shown an increase in candidemia cases following severe COVID infection and the identification of risk factors associated with candidemia. However, there is a...
3.
Erdem H, Kocoglu E, Ankarali H, El-Sokkary R, Hakamifard A, Karaali R, et al.
Int J Antimicrob Agents
. 2023 Jul;
62(3):106919.
PMID: 37423582
Objectives: Bacteraemia during the course of neutropenia is often fatal. We aimed to identify factors predicting mortality to have an insight into better clinical management. Methods: The study has a...
4.
Erdem H, Baymakova M, Alkan S, Letaief A, Yahia W, Dayyab F, et al.
Eur J Clin Microbiol Infect Dis
. 2023 Feb;
42(4):387-398.
PMID: 36790531
Fever of unknown origin (FUO) is a serious challenge for physicians. The aim of the present study was to consider epidemiology and dynamics of FUO in countries with different economic...
5.
Escrihuela-Vidal F, Kaasch A, von Cube M, Rieg S, Kern W, Seifert H, et al.
Clin Microbiol Infect
. 2022 Oct;
29(4):498-505.
PMID: 36283610
Objectives: To analyse the adherence and impact of quality-of-care indicators (QCIs) in the management of Staphylococcus aureus bloodstream infection in a prospective and multicentre cohort. Methods: Analysis of the prospective,...
6.
Euden J, Thomas-Jones E, Aston S, Brookes-Howell L, Carman J, Carrol E, et al.
BMJ Open
. 2022 Jun;
12(6):e063424.
PMID: 35697438
Introduction: Sepsis is a common, potentially life-threatening complication of infection. The optimal treatment for sepsis includes prompt antibiotics and intravenous fluids, facilitated by its early and accurate recognition. Currently, clinicians...
7.
Camp J, Filla T, Glaubitz L, Kaasch A, Fuchs F, Scarborough M, et al.
Clin Microbiol Infect
. 2022 Mar;
28(8):1149.e1-1149.e9.
PMID: 35339677
Objectives: This study aimed to investigate whether neutropenia influenced mortality and long-term outcomes of Staphylococcus aureus bloodstream (SAB) infection. Methods: Data from two prospective, multicentre cohort studies (INSTINCT and ISAC)...
8.
Devrim I, Erdem H, El-Kholy A, Almohaizeie A, Logar M, Rahimi B, et al.
Am J Infect Control
. 2022 Mar;
50(12):1327-1332.
PMID: 35263612
Background: Because central line-associated bloodstream infections (CLABSIs) are a significant complication of central venous access, it is critical to prevent CLABSIs through the use of central line bundles. The purpose...
9.
Keeley A, Nsutebu E
Pan Afr Med J
. 2022 Feb;
40:204.
PMID: 35136467
Sepsis is common and represents a major public health burden with significant associated morbidity and mortality. However, despite substantial advances in sepsis recognition and management in well-resourced health systems, there...
10.
Iregbu K, Dramowski A, Milton R, Nsutebu E, Howie S, Chakraborty M, et al.
Lancet Infect Dis
. 2021 Dec;
22(5):e143-e152.
PMID: 34914924
Neonates and children in low-income and middle-income countries (LMICs) contribute to the highest number of sepsis-associated deaths globally. Interventions to prevent sepsis mortality are hampered by a lack of comprehensive...